PROK Competitors & Alternatives
Compare ProKidney Corp. with similar stocks in the same industry
Biotechnology
PROK
Main Stock$1.41
Tradestie Score
68
Market Cap
$350.98M
Revenue Growth
-0.3%
Analyst Upside
+389.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$14.39
|
$626.91M | - | 45 | Compare |
|
SVRA
Savara Inc.
|
$4.22
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.32
|
$552.46M | - | 53 | Compare |
|
VSTM
Verastem, Inc.
|
$10.04
|
$541.60M | - | 39 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.53
|
$540.97M | - | 61 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.81
|
$529.35M | 11.2 | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.42
|
$512.39M | - | 46 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.13
|
$505.12M | 2.9 | 59 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.38
|
$492.21M | - | 53 | Compare |
More PROK Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry